Introduction
============

Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission leading to fluctuating muscle weakness that is most common in young women.[@b1-ijgm-10-131],[@b2-ijgm-10-131] Data on MG prevalence and incidence vary widely among countries. It has a prevalence rate of 15--179 per million and an incidence rate of 3--30 per million.[@b3-ijgm-10-131],[@b4-ijgm-10-131] Inpatient prevalence was 8.0 per 100,000 population.[@b5-ijgm-10-131] The prevalence rate of MG increased from 8.4 per 100,000 in 2000 to 14.0 per 100,000 in 2007, while the incidence rate was 2.1 per 100,000 population.[@b6-ijgm-10-131]

In the last three decades, MG incidence has increased in the elderly[@b2-ijgm-10-131],[@b5-ijgm-10-131],[@b7-ijgm-10-131],[@b8-ijgm-10-131] and may also be underdiagnosed[@b2-ijgm-10-131],[@b9-ijgm-10-131],[@b10-ijgm-10-131] due to atypical MG presentation in those patients. Patients with dysarthria or difficulties swallowing may be hospitalized for cerebrovascular disease workups and doctors may be unaware of any neuromuscular disorder.[@b2-ijgm-10-131] Due to the increasing prevalence of MG in elderly patients, this study aimed to investigate risk factors for MG treatment outcomes by using the national database.

Methods
=======

Study design
------------

This is a retrospective study that explored national data on MG patients aged ≥60 years and hospitalized in the year 2010. Data were retrieved from the national health insurance system. The system consisted of three kinds of health insurance: universal coverage, social welfare, and government welfare. Universal coverage is basic health insurance for the general population, while social welfare and government welfare are provided to people who work for private companies and government organizations, respectively. The *International Classification of Diseases*, Tenth Edition (ICD-10) code (G70) was used to identify eligible patients. Medical discharge forms were used to retrieve data about each patient's clinical characteristics, complications, treatments, discharge status, hospital fees, and length of hospital stay.

There are three hospital categories in Thailand including primary or community, secondary, and tertiary hospitals. The primary or community hospitals serve at the district or community levels and usually have 10--30 beds. The secondary hospitals provide health care at the provincial level, while the tertiary hospitals, such as university hospitals and large provincial hospitals, are referral centers.

Discharge statuses of all admitted patients were defined by attending physicians according to four levels: complete recovery, improved, not improved, and death. The first two categories were classified as improved or good outcomes, while the latter two were considered not improved or poor outcomes. Each eligible patient was put into one of the two groups based on these outcomes.

Statistical analysis
--------------------

Data were categorized by treatment outcomes; good and poor. Clinical features and treatment outcomes for each were compared using descriptive statistics. Factors associated with poor outcome were analyzed by multivariate logistic regression analysis. All analyses were performed with the SPSS software (IBM Corp., Armonk, NY, USA).

Ethical consideration
=====================

The study protocol was approved by the ethics committee in human research, Khon Kaen University (HE591353). Written informed consent from each patient was waived by the ethics committee because it used only retrospective, de-identified patient data.

Results
=======

During the study period, 1,948 identified MG patients were admitted to hospitals throughout Thailand. Of those, 441 patients (22.64%) were aged ≥60 years. There were 66 patients (14.97%) who had poor outcomes at discharge. The mean age of patients with poor outcomes was slightly higher than those with good outcomes (71.4 vs 69.6 years; *p*-value 0.065). The percentage of males was also slightly higher in the poor outcome group than in the good outcome group (47.0% vs 39.5%; *p*-value 0.254), as shown in [Table 1](#t1-ijgm-10-131){ref-type="table"}. The mortality rate was 9.3% or 41 patients and categorized by age group as follows: \<70 years, 17 patients; 70--80 years, 18 patients; and \>80 years, 6 patients (*p*-value for difference in age group 0.066).

Using univariate analysis, it was determined that there were five significant factors associated with poor outcomes, including the presence of pneumonia, respiratory failure, septicemia, use of mechanical ventilators, and hospital bills ([Table 1](#t1-ijgm-10-131){ref-type="table"}). Septicemia had the highest unadjusted odds ratio at 10.02. The average length of stay in the poor outcome group was longer than that in the good outcome group (15.6 vs 10.6 days; *p*-value 0.054), while the average hospital bill was significantly higher in the poor outcome group (112k vs 58k Baht; *p*-value 0.032).

After adjustment, there were only three significant factors remaining in the model. Presence of pneumonia, use of mechanical ventilators, and septicemia had adjusted odds ratios (95% confidence interval) of 2.83 (1.03, 7.75), 5.33 (2.24, 12.72), and 4.47 (1.86, 10.75), respectively ([Table 2](#t2-ijgm-10-131){ref-type="table"}).

Discussion
==========

MG is more common in young adults than in the elderly and is more prominent in females as opposed to males. The national data in our study showed that the male:female ratio in the elderly was close to one (40.6:59.4), as shown in [Table 1](#t1-ijgm-10-131){ref-type="table"}. These findings were similar to those in other studies.[@b8-ijgm-10-131],[@b11-ijgm-10-131]--[@b14-ijgm-10-131] Two studies from India and Sri Lanka found that overall male:female ratios were 2.7:1.0 and 2.0:1.2, respectively.[@b15-ijgm-10-131],[@b16-ijgm-10-131] The study from India also found that patients with ages ≥60 years were commonly male. Both studies had small sample sizes and focused on specific study populations, those associated with thymoma or undergoing immunosuppressive therapy. Generally, MG is still a disease most common in young women and elderly men.[@b8-ijgm-10-131],[@b11-ijgm-10-131]--[@b14-ijgm-10-131]

The prognosis of hospitalized MG patients in our study was good; 85% of patients were discharged with improved status. The mortality rate in the elderly subjects was higher than in the US (9.3% vs 2.2%).[@b13-ijgm-10-131] A study from Denmark and systematic review showed the highest mortality rate of 1.81 per million (range 1.5--2.2).[@b3-ijgm-10-131],[@b14-ijgm-10-131] The specific mortality rate of MG crisis was 4.47%.[@b13-ijgm-10-131] In this study, however, the mortality rate referred to overall mortality, not mortality specific to MG crisis. There were 20 patients (4.5%) who received in travenous immunoglobulin (IVIG) and 6 patients (1.4%) who received plasmapheresis, which were indicators for MG crisis. Elderly patients may have better prognoses with pyridostigmine, steroids, azathioprine, a combination of immunosuppressive drugs, IVIG, or plasmapheresis.[@b17-ijgm-10-131],[@b18-ijgm-10-131]

Treatment with surgical thymectomy is a good alternative. Patients receiving thymectomy are usually younger than patients not undergoing the operation[@b14-ijgm-10-131]--[@b19-ijgm-10-131] and have a higher remission rate.[@b19-ijgm-10-131]--[@b21-ijgm-10-131] The remission rate of MG after thymectomy was 30%--40%. There were only 13 patients (3.5%) receiving thymectomies in this study due to the elderly study population. In this study, we were not able to analyze whether or not thymectomies were associated with discharge outcomes ([Table 2](#t2-ijgm-10-131){ref-type="table"}). This finding may be explained by the fact that all patients who received a thymectomy were admitted to hospital for this operation.

Factors independently associated with discharge status were mostly due to complications during admission. Presence of pneumonia, being on a mechanical ventilator, and septicemia were factors associated with morbidity and mortality.[@b22-ijgm-10-131],[@b23-ijgm-10-131] Among these three factors, being on a mechanical ventilator was the factor with the highest adjusted odds ratio ([Table 2](#t2-ijgm-10-131){ref-type="table"}). These factors may result in longer hospital stays and higher costs. Elderly patients tend to have more complications, especially sepsis, than young adults.[@b20-ijgm-10-131]

This study used the national database. Therefore, it may represent a bird's eye view of MG. However, some limitations exist. First, data were retrieved only from discharge summaries. We were not able to identify disease severity or data for individual patients such as the age of presumed incident of MG or steroid treatment. The IVIG and plasmapheresis were seldom used in this study population due to insurance issue. Most patients in this study had basic health insurance or universal cover which meant limitation in treatment. Additionally, these results may apply only to hospitalized MG patients, not including those MG patients who were treated at the outpatient department. Data on initial MG class at admission were not evaluated, but most hospitalized MG patients in Thailand were class III or IV. Lastly, the number of patients treated with IVIG and plasmapheresis were limited due to availability of that treatment and lack of experienced physicians.

Conclusion
==========

Pneumonia, being on a mechanical ventilator, and septicemia were important factors associated with poor treatment outcomes in hospitalized elderly MG patients according to national data.
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###### 

Factors affecting treatment outcomes in elderly hospitalized myasthenia gravis patients by univariate logistic regression analysis

  Factors                                                             Outcomes (n = 441)   Crude OR      95% CI   *p*-value       
  ------------------------------------------------------- ----------- -------------------- ------------- -------- --------------- ---------
  Age, years                                              Mean (SD)   69.6 (7.2)           71.4 (7.3)    1.03     (1.00, 1.07)    0.065
  Gender                                                  Male        148 (39.5)           31 (47.0)     1        --              
                                                          Female      227 (60.5)           35 (53.0)     1.36     (0.80, 2.30)    0.254
  Insurance type                                          GWME        129 (34.4)           28 (42.4)     1        --              
                                                          SSF         16 (4.3)             0 (0.0)                                
                                                          UC          230 (61.3)           38 (57.6)     0.76     (0.45, 1.30)    0.316
  Hospital level                                          Primary     20 (5.3)             1 (1.5)       1        --              0.266
                                                          Secondary   64 (17.1)            16 (24.2)     5.00     (0.62, 40.09)   
                                                          Tertiary    75 (20.0)            14 (21.2)     3.73     (0.46, 30.12)   
                                                          Private     216 (57.6)           35 (53.0)     3.24     (0.42, 24.92)   
  Region                                                  Northern    73 (19.5)            16 (24.2)     1        --              0.489
                                                          Northeast   81 (21.6)            10 (15.2)     0.56     (0.24, 1.32)    
                                                          Central     202 (53.9)           35 (53.0)     0.79     (0.41, 1.51)    
                                                          Southern    19 (5.1)             5 (7.6)       1.20     (0.39, 3.69)    
  Pneumonia[a](#tfn2-ijgm-10-131){ref-type="table-fn"}    No          353 (94.1)           46 (69.7)     1        --              
                                                          Yes         22 (5.9)             20 (30.3)     6.98     (3.54, 13.76)   \<0.001
  Respiratory failure                                     No          342 (91.2)           40 (60.6)     1        --              
                                                          Yes         33 (8.8)             26 (39.4)     6.74     (3.66, 12.39)   \<0.001
  Septicemia[a](#tfn2-ijgm-10-131){ref-type="table-fn"}   No          356 (94.9)           43 (65.2)     1        --              
                                                          Yes         19 (5.1)             23 (34.9)     10.02    (5.05, 19.88)   \<0.001
  Intravenous immunoglobulin                              No          356 (94.9)           65 (98.5)     1        --              
                                                          Yes         19 (5.1)             1 (1.5)       0.29     (0.04, 2.19)    0.229
  Plasmapheresis                                          No          371 (98.9)           64 (97.0)     1        --              
                                                          Yes         4 (1.1)              2 (3.0)       2.90     (0.52, 16.15)   0.225
  On continuous invasive MV                               No          329 (87.7)           32 (48.5)     1        --              
                                                          Yes         46 (12.3)            34 (51.5)     7.60     (4.29, 13.48)   \<0.001
  Thymectomy                                              No          362 (96.5)           66 (100.0)                             
                                                          Yes         13 (3.5)             0 (0.0)                                
  Length of stay, days                                    Mean (SD)   10.6 (17.7)          15.6 (22.2)   1.01     (1.00, 1.02)    0.054
  Hospital charge (× 10,000)                              Mean (SD)   5.8 (15.5)           11.2 (17.3)   1.02     (1.00, 1.03)    0.032

**Notes:** Data presented as number (%), unless indicated otherwise.

Acquired after admission to hospital. '--' indicates no data.

**Abbreviations:** OR, odds ratio; CI, confidence interval; GWME, Government Welfare Medical Expense; SSF, Social Security Fund; UC, universal coverage; MV, mechanical ventilator; SD, standard deviation.

###### 

Significant factors affecting poor treatment outcomes in elderly hospitalized myasthenia gravis patients by multivariate logistic regression analysis

  Factors                     Adjusted odds ratio   95% confidence interval   *p*-value
  --------------------------- --------------------- ------------------------- -----------
  Pneumonia                   2.83                  1.03, 7.75                0.043
  On continuous invasive MV   5.33                  2.24, 12.72               \<0.001
  Septicemia                  4.47                  1.86, 10.75               0.001

**Abbreviation:** MV, mechanical ventilator.
